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Abstract 
 
 
Introduction: Despite known associations between obesity and the development of 
cardiovascular disease, the relationship between obesity as reflected by BMI and 
angiographically demonstrated CAD is not fully understood.  Moreover, this relationship has not 
been adequately defined in black patients, a group demonstrated to have lower rates of 
angiographic CAD despite higher rates of traditional CAD risk factors, cardiovascular events, 
and CAD-related mortality.  In order to more fully characterize the association between obesity, 
race, and CAD, a systematic review and subsequent analysis of secondary data from a major 
academic medical center was performed.  The review informed the approach to the analysis and 
underscores the significance of the resulting manuscript—with potentially important clinical 
implications in the evaluation and management of patients with suspected CAD. 
Methods: The review canvassed literature using multiple academic search engines.  The 
contribution of obesity to black-white differences in angiographically demonstrated CAD proved 
too narrow a topic for an adequate systematic review; therefore the study focus was broadened to 
include articles evaluating the relationship between BMI and CAD.  Potential studies for full 
review were narrowed using appropriate inclusion and exclusion criteria.  Systematic data 
extraction facilitated the organized comparison of internal and external validity, strength of 
evidence, and overall quality of selected studies. The secondary data analysis was performed 
using an angiography database from a single academic hospital.  We studied patients undergoing 
first-time, non-emergent angiography from 2001 to 2010.  From this cohort, we selected those 
lacking a previous CAD diagnosis, without previous cardiac intervention, and with complete 
anthropomorphic measures and outcome data.  Using models that controlled for patient 
demographics and CAD risk factors, we compared rates of angiographic disease for blacks and 
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whites by obesity status (BMI ≥ 30 kg/m2) and BMI class.  Significant CAD was defined by the 
presence of a significant lesion (≥50% stenosis in the left main artery or ≥70% stenosis 
elsewhere), and also quantified by a modified Gensini score of global disease. 
Results: The review found three out of five studies to lack sufficient, overall quality as to draw 
reliable conclusions from their results.  The two stronger studies found no consistent relationship 
between BMI and CAD, with statistically nonsignificant inverse relationships.  In preparation for 
the original manuscript’s analysis, we identified 4,022 white and 1,963 black eligible patients.  
Black patients had higher rates of diabetes and hypertension, and were more likely to be obese 
than whites (OR 1.85;95% CI 1.65-2.06).  Nevertheless, black patients were less likely to have a 
significant stenosis (adjusted OR 0.57; 95% CI 0.48–0.66), and were found to have a lower mean 
Gensini score (7.33 vs. 8.83, P=0.001).  Obesity was not associated with the presence of CAD.  
In fact, black obese patients were significantly less likely to have a severe stenosis than their 
non-obese counterparts, and there was a non-significant trend for obese patients of both races to 
have less disease than non-obese patients using the Gensini score.  
Conclusions: The literature is underfunded with evidence describing the relationship between 
obesity, race, and CAD.  Previous studies suggest there is no association between obesity and 
CAD despite ultimately higher rates of cardiac morbidity and mortality in the obese.  Black 
patients in this study’s cohort were more likely to be obese than white patients yet were far less 
likely to have significant CAD.  Moreover, obesity itself was not positively associated with the 
presence or severity of CAD, suggesting that obesity may lead to cardiovascular morbidity and 
mortality by mechanisms other than the development of atherosclerosis, particularly in black 
patients. 
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Systematic Review 
 
INTRODUCTION 
 The growing epidemic of obesity is a major public health concern.  In light of this trend, 
increasing relevance of overweight- and obesity-associated morbidity and mortality has directed 
attention to the role of excess body fat in various disease states.  Several risk factors for heart 
disease are associated with adiposity, including diabetes, hypertension, endothelial dysfunction, 
and lipid disorders.
1-3 
Many studies have established the strong association between obesity, as 
measured by body mass index (BMI), and the incidence of coronary events.
4-11
 Long-term 
follow-up studies found that obesity may be associated with heart disease independent of other 
risk factors.
12-14
 Thus, the contribution of excess body fat to the eventual development of heart 
disease and subsequent cardiac events is one of confirmed significance.  The American Heart 
Association echoes the totality of the evidence by defining obesity as a major risk factor for the 
development of cardiovascular disease.
15
 
However, despite the known associations between obesity and heart disease, the 
relationship between BMI and angiographically detected coronary artery disease (CAD) remains 
controversial.  Past studies have reported inconsistent results on the relationship of BMI and 
CAD.
16-26
 Conclusions regarding the association are predominantly negative (no association) but 
also include U-shaped, positive, and threshold effects of obesity on angiographically detected 
CAD.  Given the biological plausibility of a positive association between obesity and CAD, the 
pattern of negative studies challenging pathophysiological logic is puzzling.  The purpose of this 
review is to assess the effect of excess adiposity, as measured by BMI, on the incidence of CAD 
determined by angiography.   
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METHODS 
Search Strategy 
 An electronic search of MEDLINE, ISI Web of Knowledge, and Google Scholar were 
used to search for pertinent studies.  Keywords utilized to narrow search results included: 
Obesity; Coronary Artery Disease, Coronary Angiography, Body Mass Index, Atherosclerosis, 
Adiposity, CAD Severity; Body Fat; Gensini; Duke Myocardial Jeopardy Score; Coronary Heart 
Disease; Cardiovascular Disease; and Weight.  Citations of relevant studies in articles using this 
strategy were also included.  Additional original articles cited by papers found using this search 
strategy were also considered and included pending satisfaction of inclusion criteria.   
Article Inclusion 
Articles chosen for review were limited to English, original papers published in peer-
reviewed journals since 1990.  Titles and abstracts were reviewed to confirm relevance. 
Specifically, studies must have evaluated the existence of a relationship between obesity and 
CAD as measured by BMI and coronary angiography, respectively.  Review articles, papers cited 
by relevant studies but not found with direct searches, case reports, and studies that included the 
independent and dependent variables of interest without an analysis of their association or lack 
thereof (i.e. examining a related set of variables to answer a different research question such as 
the association of waist circumference to incidence of cardiac events) were excluded.  Many of 
the relevant articles found using this strategy also evaluated the effects of other variables on 
CAD (e.g. inflammatory markers, body fat percentage, fat distribution, etc.), or otherwise did not 
exclusively focus on CAD and BMI; these articles were included.   
Data Extraction 
Once an article was selected for full review, pertinent data points were abstracted by a 
single author (CS) from the publication and organized into a pre-designed evidence table that 
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included fields such as design, population, methods, outcome measures, and results.  This 
juxtaposition of study characteristics facilitated the evaluation and comparison of relevant 
papers.  Papers chosen for full review were evaluated for internal and external validity based on 
the GRADE system of judging quality of evidence.  These qualifications of the evidence 
presented in a particular study are based on they type of study (randomized trial, observational 
study, etc.) and shaped by limitations to study quality, inconsistencies, uncertainties about 
directness, precision of data, bias, effect magnitude, statistical significance, and the presence and 
controlling of confounders.
29 
 
RESULTS 
The search strategy yielded 764 titles across three search engines using the combined 
yield of each keyword search.  These results were then filtered for relevance, publishing date, 
and language.  The remaining 55 studies were furthernarrowedto 11 by excluding those lacking 
abstracts, with poor CAD quantification, and those studies that quantified adiposity by waist 
circumference, weight, body fat percentage, and additional modalities other than BMI.  Of the 11 
original articles that examined the association of BMI and angiographically assessed CAD, five 
were selected for further analysis based on appropriate outcome measures (validated 
approximations of global disease, criteria for significant stenosis, etc.), availability of full text, 
and a specific focus on the association between BMI and CAD.  Our process of evaluating the 
literature for relevant studies is summarized in a flow diagram at the end of this review (Figure 
1).
 
Of the five articles chosen for full review, we identified one prospective observational 
cohort study, one retrospective cohort study, one case-control study, and two cross-sectional 
studies.  Quality scores overall were unimpressive due to ethical and logistic inabilities to frame 
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pertinent studies as randomized control trials, limitations of the exposure and outcome measures, 
generalizability of study populations, inadequate controlling of confounders, and other 
shortcomings of internal and external validity. The authorship and publication information, 
design, population, methods, outcome measures, and results for these five studies are 
summarized at the end of this review in a QUOROM flow diagram (Table 1).
28
 
Analysis 
 The first article by Rossi et al.
22
 was a prospective cohort study that examined a 
population of 1,299 patients suspected of having CAD to determine if a statistically significant 
association existed between BMI and angiographically determined CAD, coronary events, 
inflammatory markers, endothelial function or mortality.  This was the largest study of the eleven 
pertinent, original articles.   
Almost half of the cohort was overweight (43.6%), and 19.6% were obese.  The 
anthropomorphic exposure measures were BMI and body surface area, both calculated 
conventionally from height and weight measurements taken before angiography.  Supporting the 
aforementioned studies on the cardiovascular risks of obesity, they did find that overweight and 
obese subjects had a higher incidence of coronary events compared to the subjects of normal 
weight.  However, rates of CAD (detected by angiography) did not differ significantly between 
BMI groups.  Mean Gensini scores (a quantification of CAD severity incorporating both degree 
of coronary narrowing and importance of stenosed vessel) were 34.8 ± 29.5, 36.6 ± 30.8, and 
32.9 ± 28.8 for normal weight, overweight, and obese subjects, respectively.   
This study had several strengths, including power (size), control for cardiovascular risk 
factors, generalizability (high external validity given consecutive patient enrollment at a large 
medical center under typical referral circumstances), and exclusion of patients with acute 
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coronary syndrome, history of CAD, valvular disease, prosthetic valves, congenital heart disease, 
hypertrophic cardiomyopathy, and those on dialysis.   
Weaknesses include wide confidence intervals of mean Gensini scores, and the inherent 
limitations of a prospective observational study—wherein causality cannot be established, only 
associations. Statistically significant difference in coronary events was based on adjusted risk 
ratios within 0.17 of 1.0.  Thus, statistical significance here may exist without clinical 
significance.  The cutoff for a significant stenosis in this study (30% for left main artery (LMA) 
and 50% elsewhere) was lower than what similar studies typically use, threatening specificity.  
Overall, this was a well-done study and supports the pattern of negative studies that investigate a 
significant relationship between BMI and angiographically detected CAD. 
 The second article by Phillips and Roberts
20
 was a retrospective cohort, comparing BMI 
in 842 patients undergoing coronary angiography at a major academic medical center.  Subjects 
were defined as having CAD if they had at least one vessel with an occlusion of greater than 
50%.  Subjects with less disease than this were considered to not have CAD.  The two groups 
were then stratified by clinical presentation (e.g. stable angina, unstable angina, etc.) and rates of 
having CAD were compared across BMI groups.   
Comparison of the BMI in the 624 patients in whom >1 coronary artery was narrowed 
>50% in diameter to the BMI in the 218 patients with absent or lesser degrees of coronary 
narrowing disclosed the following: the BMI was >30 in 209 (33%) versus 92 (42%) patients (p 
0.008): BMI was 26 to 30 in 233 (37%) versus 80 patients (37%) (p>0.05), and BMI <25 (ideal) 
in 182 (29%) versus 46 (21%) patients (p 0.01).
20
 There were many limitations to this study that 
undermine the positive correlation found to exist between BMI and CAD.   
The authors rationalized this study by stating no other articles examining BMI and 
angiographic CAD were found in their literature search besides one
27—which had all female 
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subjects. The authors implied publication was worthy by the incorporation of both males and 
females into their study.  However, six of the eleven aforementioned relevant articles had been 
published with subjects of both sexes before the date of Phillips and Roberts study.  More 
importantly, no confounding variables were controlled for; the statistical analysis was a simple z-
test to determine statistical significance.  The bulk of the paper ends up being scatter plots and 
discussion of coronary events stratified by age, information irrelevant to the primary research 
question.  Without accounting for other cardiovascular risk factors, a true correlation between 
BMI and CAD cannot be determined without the risk of missing the influence of weight-related 
confounders.   
Another limitation was the dichotomizing of subjects into either having CAD or not 
having CAD by visual inspection.  Similar studies employ some degree of quantitative 
assessment or systematic evaluation of CAD severity, while this study relied upon the 
subjectivity of many different angiographers visually gauging whether or not a vessel was half 
stenosed.  Therefore, although the findings of this study support the biological plausibility of a 
significant relationship existing between BMI and CAD, its weak internal validity render its 
conclusion unreliable.   
 The next article by Tanaka et al.
17
 is a cross-sectional study from Japan.  The subjects 
were 532 patients who underwent coronary angiography for suspicion of CAD, all of whom were 
at least 30 years of age.  Weight and height information were obtained from medical records and 
calculated BMI was compared to the outcomes of number of diseased vessels, Gensini score, and 
significant stenosis—defined as at least a 50% narrowing of the LMA or at least a 75% 
narrowing elsewhere.   
The association between BMI and CAD was tested with sex-specific multiple logistic 
regression analysis controlling for age, hospital trends, and several coronary risk factors 
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identified from medical records and a questionnaire.  Utilizing either number of diseased vessels 
as the dependent variable, BMI was positively correlated in men but not in women (multivariate 
OR of 1.0 (reference), 1.1, 1.9, and 2.5, p 0.02.  Neither the Gensini nor the significant stenosis 
outcomes were associated with BMI.  The authors of this study did an excellent job outlining 
exclusion criteria, including history of MI, aorta surgery, angioplasty, cardiomyopathy, 
congenital heart defects, and valvular disease.  Thorough efforts were made to ascertain 
cardiovascular risk profiles, supplementing much of the missing information in medical records 
with a survey addressing issues such as smoking habit, diabetes diagnosis, hyperlipidemia 
medication. Sex-specific multiple logistic regression controlled for the identified risk factors to 
isolate the effect of BMI on CAD, while the three dependent variables provided a more accurate 
estimate of a subject’s atherosclerotic status.   
The results of the study however are ultimately not convincing for a few reasons.  The 
bivariate Gensini score, firstly, is set at a very low cutoff.  Equating a Gensini score of greater 
than 10 with severe/present CAD is a gross overestimate of disease and would mislead the reader 
to think CAD was present more often than it really was.  To illustrate, the positive version of the 
other dichotomized dependent variable, significant stenosis (greater than 50% LMA or 75% 
elsewhere) would be 20 at minimum.  Also, the surveys are subject to reporter and recall bias—
particularly when dealing with social stigmas such as smoking and other behavioral habits that 
represent risk factors.  Finally, even though the adjusted odds ratio was statistically significant at 
p 0.02, the 95% confidence intervals included 1.0 for all BMI categories.  It is also difficult to 
control for Asian diet, lifestyle factors, etc. in this exclusively Japanese (they do live the 
longest!) cohort and that may hinder generalizability to other populations.  Given the limitations 
of this study and less-than-impressive statistics, neither its negative nor positive findings can be 
regarded as confirmation or refutation of a BMI/CAD correlation. 
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 The fourth study by Zamboni et al.
18
 is a case-control of 43 patients who were referred 
for angiography based on suspicion for CAD or the occurrence of a coronary event.  Of the entire 
study sample, 33 of the subjects were diagnosed angiographically with CAD based on a modified 
Reardon score, while the 10 found to be without disease were used as controls.  In addition to 
BMI and other anthropometric data, computed tomography was utilized to precisely define 
percentage and distribution of body fat.  BMI, along with body weight, total and subcutaneous 
abdominal adipose tissue were found to have no statistical difference between the cases and 
controls.   
Supporting the finding of many studies, visceral abdominal adipose tissue was found to 
be greater in subjects with CAD.  Subjects who reported significant weight loss in the six months 
prior to the study were excluded.  This is important because it limits the confounding effects of 
chronic illness (e.g. cancer) on atherosclerosis in subjects with normal or low BMI’s.  While the 
authors of this study should be credited with employing the accurate imaging of computed 
tomography to assess body fat, it does not contribute to the question of linking BMI to CAD and 
is an expense that clearly limited the study population.   
The exclusion and inclusion criteria were counterintuitive, with 18 of subjects with CAD 
having had an MI, while those with hypertension were excluded from the study.  Only two of the 
controls did not have valvular disease. This clearly represents a skewed incidence of heart 
disease in comparison with the general public, and thus invalidates the use of this group as 
controls.  Also, no women were included in the study.  Although the findings of this paper 
support the majority of similar studies, the authors’ conclusion that BMI is not correlated with 
CAD cannot be trusted given the abundance of limitations to both internal and external validity.   
 The final article is a cross-sectional study by Auer et al. of 1101 subjects undergoing 
angiography at a tertiary care center.
19
  Aside from those with congenital heart disease, all 
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patients referred to this center for angiography over a four-month period were included in the 
study population. BMI and body fat (as measured by bioelectrical impedance analysis) were the 
main exposure variables, with outcomes including significant stenosis (at least 40% narrowing of 
LMA at least 50% in another arterial segment), number of involved vessels, and an originally 
modified CAD severity score.   
BMI did not significantly vary according to number of involved vessels or the modified 
CAD severity score.  BMI showed a statistically nonsignificant inverse relation to the presence 
of significant stenosis.  The lack of association between BMI and the various angiographic 
measures of CAD is interesting given that traditional cardiovascular risk factors including 
diabetes and hypertension were much more common in those with higher BMI’s.  Adjusting for 
potential confounders (including diabetes, hypercholesterolemia, smoking, and hypertension) did 
not change the lack of association.  Strengths of the study include the large size; this study 
population is the second largest of its kind.   
The authors of this study did an excellent job in outlining and controlling for potential 
confounders and stratifying analyses by both sex and age.  Of note the study also considers the 
effect of BMI on CAD without adjustment, which is important because the ultimate objective of 
establishing the existence or absence of a significant association between BMI and CAD is 
identifying the value of BMI in risk stratification; increased BMI may be associated with other 
CAD risk factors and thus an adjusted analysis may inappropriately reduce the association 
between BMI and CAD as defined by angiography.  In other words, a casual component of CAD 
(e.g. higher blood pressure from higher BMI) should not be corrected for in statistical 
adjustments.  Limitations included the aforementioned inherent inability of a cross-sectional 
study to establish causality—only association.  The study population, while more generalizable 
than similar studies, represents an inhomogeneous cohort regarding age, gender, and 
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comorbidities.  Overall, this is a strong study with impressive internal and external validity.  Its 
conclusions support the predominance of negative studies and should be incorporated into the 
body of credible evidence refuting a BMI/CAD association. 
 
DISCUSSION 
The overall strength of the evidence presented by the five relevant studies is fair; 
inconsistent conclusions, widely ranging study samples, study designs, and outcome measures 
illustrate the limitations to the current literature regarding this topic. Only two of the five 
selected original articles were designed with strong enough validity to draw reliable conclusions.  
Based on these two relatively strong papers, and the predominance of related articles, it appears 
that the pattern of negative studies suggests the true lack of association between BMI and 
CAD.
19,22
 
It is evident in the limitations of these reviewed studies that assessing the relationship 
between obesity, as measured by BMI, and CAD, as measured by angiographic CAD, presents 
known and unknown challenges to study design.  Several weaknesses inherent to this topic can 
inform future research initiatives, including the fact that obese individuals have higher rates of 
false positive noninvasive testing, thus more obese people without CAD are referred for 
angiography simply to rule it out.  Also, coronary angiographic data are lacking in subjects 
without any suspicion of CAD.   
Those who undergo coronary angiography are usually referred for signs or symptoms and 
thus the available data cannot accurately reflect the population at large—and thus the obese 
population at large.  An intrinsic weakness of the BMI metric is an inability to differentiate lean 
mass and body fat.  A short, very muscular person could have the BMI of a tall morbidly obese 
person without, of course, the same risk for CAD.  Also, the relationship between BMI and 
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excess adiposity varies across race.  Black patients have less body fat than their 
Caucasiancounterparts of the same BMI. 
 Investigators have proposed that obesity influences acute cardiac events rather than the 
development of atherosclerosis, explaining the higher morbidity and mortality of those with 
higher BMI’s; the contribution of obesity to atherosclerotic plaque’s ―vulnerability‖ could be 
incorporated into future studies.   Future study designs should pay greater attention to race data, 
given the surprisingly lower rate of angiographically detected CAD in minority populations 
despite significantly higher rates of risk factors compared to whites.     
The trend of BMI being found to be negatively associated with CAD suggests obesity to 
be protective against the development of atherosclerotic heart disease, though we know this to 
not be the case.  Explanation for this paradox may exist in confounders that have not yet been 
addressed.  Relevant studies that evaluate the association between BMI and CAD are faced with 
many challenges.  In particular, it is difficult to control for the low threshold at which primary 
care physicians and cardiologists refer their obese patients for coronary angiography to rule out 
CAD.  Noninvasive testing for ischemic heart disease is both difficult and fraught with false 
positives within the obese demographic, which populates catheterization labs with obese, 
disease-free patients.  These obese patients without stenotic coronary plaque confound 
conclusions drawn from databases and obscure the true relationship between adiposity and 
angiographic CAD. 
 
CONCLUSION 
 BMI does not appear to correlate with CAD, given the inconsistency of study 
conclusions.  The predominance of studies examining BMI and CAD are negative, and of the 
reviewed articles, the strongest evidence presented is consistent with these findings. More 
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accurate screening modalities for obese patients with suspected disease will correct this 
phenomenon, and future study designs that account for referral confounders may reveal a more 
accurate association between BMI and CAD. 
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Table 1. Study Profiles 
Study 
Citation 
Design Population Methods Outcome 
Measure 
Results Quality 
Rating 
Rossi R, 
Iaccarino D, 
Nuzzo A, et 
al. 2009.
22 
Prospective 
cohort 
1299 
consecutive 
patients at 
one medical 
center 
undergoing 
coronary 
angiography; 
43.6% OW, 
19.6% OB; 
No race data. 
Quantified 
atherosclerotic 
burden with 
three outcomes; 
examined 
comorbidities, 
inflammatory 
states, f/u 
cardiac events 
Significant 
stenosis, 
Gensini, # 
diseased 
vessels 
No association 
between BMI 
and CAD 
Good 
Phillips SD, 
Roberts W. 
2007.
20 
Retrospective 
cohort 
843 patients 
at one center 
undergoing 
angiography 
for suspected 
CAD; No 
race data. 
Compared rates 
of obesity 
between two 
groups: those 
with at least one 
50% stenosis 
and those 
without 
Significant 
stenosis 
Positive 
relationship 
between BMI 
and CAD. 29% 
of CAD group 
had BMI>30; 
21% of non-
CAD group had 
BMI>30 
Fair 
Tanaka K, 
Kodama H, 
Sasazuki S, 
et al. 2001.
17 
Cross-
sectional 
532 Japanese 
patients 
around one 
city referred 
for first time 
angiography 
BMI quartile 
association with 
outcome 
variables, 
examined body 
fat distribution 
as well.  
Bivariate 
Gensini of < or 
>10—
underestimate? 
Significant 
stenosis, 
Gensini, # 
diseased 
vessels 
Obesity 
associated with 
CAD in males 
but not females. 
Fair 
Zamboni M, 
Armellini F, 
Sheiban I, et 
al. 
cardiology. 
1992.
18 
Case-control 43 patients, 
10 of which 
w/o 
angiographic 
CAD; no 
race data. 
Exposures: body 
fat %, BMI, 
body fat 
distribution from 
CT to compare 
patients with 
and without 
angiographic 
CAD 
Modified 
Reardon 
score 
Distribution of 
fat, not BMI, 
differed 
between groups. 
Visceral 
abdominal 
adiposity was 
associated with 
CAD. 
Poor 
Auer J, 
Weber T, 
Berent R, et 
al. 2005.
19 
Prospective 
cohort 
1101 
subjects, 
―most‖ 
referred for 
s/sxs of 
CAD; no 
race data. 
Exposures: BMI 
and calculated 
body fat 
# severe 
stenosis 
(>40% 
narrowing in 
LMA or >50 
elsewhere), 
Angio-score 
Neither BMI 
nor BF was 
associated with 
CAD severity 
Good 
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Figure 1. QUOROM Study Selection Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Titles found using keyword searches (n=764  ) 
Excluded  (n= 709  ) 
 Not addressing CAD or Obesity (n=661) 
 Published before 1990 (n=36) 
 Other language (n=12) 
Retrieved for full review (n= 11) 
Excluded (n= 44) 
 Obesity not measured by BMI (n=18) 
 Abstracts unavailable (n=11) 
 CAD not quantified by angiography (n=15) 
Analyzed for full review (n= 5) 
 
 
Retrieved for relevance assessment (n=55 ) 
Excluded (n=6) 
 Association between BMI and 
CAD not fully addressed (n=2) 
 Inappropriate outcomes (n=3)  
 Full text unavailable (n=1)  
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Introduction 
 Ischemic heart disease is the leading cause of death in the U.S., and there remain 
significant gaps in our understanding of coronary artery disease (CAD), particularly in black and 
obese patients.  Black patients have consistently been shown to have a lower angiographic 
burden of CAD, despite higher rates of traditional risk factors and poorer outcomes.
1-7 
Likewise, 
obese patients have significantly higher rates of adiposity-associated risk factors for heart disease 
including diabetes, hypertension, endothelial dysfunction, and lipid disorders.
8-10 
Excess 
adiposity has also been positively associated with the incidence of coronary events.
11-22
 
However, past studies have reported inconsistent results on the relationship of BMI and CAD.
23-
33
  No studies to date have examined this relationship in a separate cohort of white and black 
patients. 
The low rate of angiographic CAD in blacks, coupled with high rates of obesity in this 
group suggests that there may be a different relationship between BMI and disease in white and 
black patients.
 23,34-36, 
Understanding the relationship between obesity and CAD, as it varies by 
race, can aid in our understanding of the development of CAD and its variable presentation in 
different groups.  In this study, we examine patients undergoing initial non-emergent 
angiographic evaluation to (i) confirm differences in angiographically detected significant CAD 
between black and white patients, (ii) understand differences in angiographically detected 
significant CAD between obese and non-obese patients, and (iii) determine whether the 
association between obesity and CAD differs between white and black patients. 
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Methods 
Study Design and Data Collection 
This study is a secondary analysis of a comprehensive database of all cardiac 
catheterizations performed at a single academic medical center in the southeastern United States. 
The hospital uses Apollo software, a proprietary reporting program (Lumedx, Oakland, CA) for 
data capture, storage, and reporting to the National Cardiovascular Disease Registry.
37
 Prior to 
each catheterization procedure, patient demographics are entered into the database by a 
registration clerk and trained catheterization lab technicians and nurses while patient medical 
history and the clinical circumstances of the catheterization are entered by cardiology fellows. 
Following the procedure, detailed information on coronary anatomy findings, including the 
maximum percent stenosis found within each vessel, is entered by the physician who performed 
the procedure. A research nurse who is responsible for the integrity and consistency of the data 
subsequently reviews the data. Global data reviews are performed annually to ensure accuracy. 
Study Sample 
 The database included 33,119 catheterization procedures performed from its inception 
through 24 October 2010. We identified 20,201 first-time, registry-listed cardiac catheterizations, 
and then selected the 12,256 of these that were performed after 1 August 2001 when data on 
coronary stenosis and severity were first routinely recorded. Of these individuals, 10,888 were at 
least 18 years of age at the time of procedure. For these patients undergoing a first angiography 
at this hospital, 2,544 were excluded for having previously confirmed CAD: 1,155 were 
excluded for having previous angiographic intervention, 544 for having a history of coronary 
artery bypass surgery, and 845 for having a history of myocardial infarction. Another 1,503 were 
excluded for presenting with an acute coronary syndrome  (e.g. NSTEMI, STEMI, etc.), as these 
patients have a diagnosis with a high likelihood of significant CAD and an indication for urgent 
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or emergent catheterization.  Of the remaining 6,841 individuals, 6,136 were identified as black 
or white. Another 138 were dropped for missing BMI measurements. These exclusion criteria 
reduced the sample to 5,998 patients in an attempt to target black and white patients undergoing 
first angiography under elective circumstances for suspected, but not yet confirmed, CAD. 
Study Variables of Interest 
 Prior to data analysis, we selected two outcome variables determined to be reflect 
coronary artery disease severity: a modified Gensini score which summarizes the total burden of 
disease in all the vessels and ―significant stenosis‖ outcome which reflects a high degree of 
stenosis in at least one vessel.   The dichotomous significant stenosis variable was created from 
existing variables in the dataset defining stenosis in each major coronary artery segment assessed 
at angiography (left main artery, proximal left anterior descending, mid-distal left anterior 
descending, left circumflex, right coronary artery), and was defined as either ≥50% stenosis in 
the left main artery or ≥70% stenosis in any other segment.  The modified Gensini score is based 
on the original scoring system that has been adapted by other relevant studies; it was created 
from existing variables in the dataset defining stenosis in five major coronary artery segments.
38
  
Stenosis values from five major arterial segments (left main artery, left anterior descending, right 
circumflex artery, circumflex, distal left anterior descending) ranging from 0-100% were 
converted to severity coefficients accordingly: <25%=0; 25-49%=1; 50-74%=2; 75-89%=4; 90-
98%=8; 99%=16; and 100%=32.  A lesion score was the product of the severity coefficient and 
the location coefficient, which incorporates the importance of a certain vessel in regard to 
myocardial perfusion.  The modified Gensini score for each patient was the sum of all lesion 
scores.The score was used both as a continuous measure and also dichotomized for the purpose 
of the analysis.  The threshold score to define ―severe disease‖ was set at 10 points based on 
other studies
39,40
 and angiographic equivalence to the ―significant stenosis‖ criteria.   
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 Covariates for the multivariable analyses included age, sex, and traditional CAD risk 
factors (hypertension, diabetes, hyperlipidemia, smoking status, and family history of premature 
cardiovascular disease). All the independent variables are binary with the exception of age 
(continuous in years) and BMI (used both continuously and in strata in kg/m
2
).   
 Race information for each patient was entered by catheterization lab nurses and fellows, 
typically by copying race information recorded in the hospital’s electronic patient medical 
records. Race information in the electronic patient medical records is available in two locations: 
on a patient demographics page that presents information recorded by registration clerks for 
administrative purposes and within physicians’ clinical notes. In most cases, it is likely not self-
reported. 
Analysis Strategy 
 We compared characteristics and CAD risk factors among patients in our sample by race, 
obesity status, outcome, and outcome stratified by race, and tested for significance using 
Pearson’s χ2-test within categories and two-tailed t-tests for continuous measures.  
 Logistic regression modeling was used to examine the independent association of obesity 
with the likelihood of significant stenotic disease (defined by the dichotomous ―significant 
stenosis‖ outcome, or a Gensini score equal or greater than 10), controlling for traditional CAD 
risk factors and demographics. We then fit separate logistic regression models by race.  
ANCOVA was used to compare adjusted and unadjusted mean modified Gensini scores by BMI 
and race.  Patients with missing outcome data were excluded from the multivariable analyses.  
 Data analysis was performed using STATA (version 10.1; College Station, TX) statistical 
software program. All statistical testing was two-sided with the level of significance set at P ≤ 
0.05. This study was approved by the Biomedical Institutional Review Board of the University of 
North Carolina at Chapel Hill (Chapel Hill, NC). 
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RESULTS 
Sample patient characteristics and comparison by race 
 Of the 5,998 patients undergoing initial elective catheterization, approximately one-third 
(32.8%) were black. Slightly over half were male and almost half were obese.  Black patients in 
the sample were significantlyyounger, more likely to be female, and had a greater prevalence of 
obesity, diabetes and hypertension (Table 1). Rates of smoking and hyperlipidemia were 
comparable between black and white patients. 
CAD risk factors 
As expected, traditional risk factors for CAD (age, smoking, hypertension, 
hyperlipidemia, diabetes, and family history) were associated with positive findings on 
angiography (Table 2). For example, among patients with hypertension, the odds of having a 
significant stenotic lesion on angiography were over twice that of patients without hypertension 
(OR 2.22; 95% CI: 1.60-2.50).  Similarly, the mean Gensini score for those with traditional CAD 
risk factors were consistently higher than those without the risk factor (P < 0.001 for all). 
The odds of severe CAD initially increased along with BMI until risk peaks at Class I 
obesity (BMI of 30-34.9 kg/m
2
) for both races (Table 2). After which point, risk for disease then 
decreases with increasing BMI.  However, the decrease in risk seen with increasing adiposity is 
exaggerated in blacks; very obese (Class III, BMI of >40 kg/m
2
) black subjects were half as 
likely to have a significant coronary stenosis compared to black, underweight subjects (OR 0.51, 
95% CI 0.20-1.33).  In contrast, very obesewhite subjects were equally likely to have a 
significant coronary stenosis compared to white, underweight subjects (OR 1.05 95% CI 0.61-
1.82).  Mean Gensini scores followed the same pattern with increasing BMI, reflecting the initial 
increase and eventual decrease in odds of disease that wasamplified in black subjects.  Adjusting 
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for demographics and CAD risk factors mitigated the difference in odds of disease between 
obese and non-obese subjects. 
Trends of Disease by Obesity 
Among the entire sample, 42.5% of patients were obese (defined as a BMI greater than 
30 kg/m
2
).  The mean BMI of the sample patients was 30.2 kg/m
2
.  Obese patients were younger, 
more likely to be female, less likely to smoke, and had a greater prevalence of hypertension, 
hyperlipidemia, diabetes, and family history of CAD (Table 3).  Rates of CHF were comparable 
between obese and non-obese patients.  Obese patients were less likely to have a significant 
stenosis when compared to their non-obese counterparts (OR 0.79, 95% CI 0.71-0.89).  
Likewise, the mean Gensini score for obese subjects was 1.5 points lower than for non-obese 
subjects (P < 0.001).  When stratified by BMI class, prevalence and severity of CAD (as 
quantified by mean Gensini score and odds ratio for significant stenosis) correlated to body mass 
in an upside down, U-shaped relationship (Figure 1).   
This pattern was also seen when comparing percent with significant stenosis and mean 
Gensini score by race and BMI class (Table 3).  However, despite BMI class or obesity status, 
black patients were consistently found to have less disease as measured by the two outcomes.  
Nonetheless, obese patients of either race were repeatedly found to have less disease than their 
underweight, normal weight, and overweight counterparts.   
 
Black patients and angiographic burden of disease 
 Among the entire sample, 29.4% of patients were found to have significant stenosis. 
However, there were significant differences between the race groups. Black patients were less 
likely to have significant stenosis compared to whites (OR0.49, 95% CI 0.43–0.55) (Table 4). 
The findings of a relatively lower prevalence of angiographic disease among blacks did not 
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change substantially after adjusting for demographics and CAD risk factors, with black patients 
still less likely (OR 0.57, 95% CI 0.48– 0.66) to have significant stenosis compared to whites.  
The outcome was similar using modified Gensini score (Table 4). 
 When the odds ratios for both outcomes were stratified by BMI class and compared 
across race, we again see the inverse parabolic relationship between body mass and severity of 
disease.  In particular, the adjusted odds ratios of severe disease in patients with stage III obesity 
(>40 BMI) were approximately half those of other BMI classification (Table 5).  The protective 
effect of severe obesity was larger in the black population.  Interestingly, black, stage III obese 
patients were half as likely to have severe CAD compared to their black, underweight 
counterparts (Table 2).  White, stage III obese patients had equivalent odds of severe CAD 
compared to their white, underweight counterparts. 
Race, obesity, and burden of disease 
 The effect of excess adiposity on odds of severe CAD varied between races.  Both black 
and white subjects exhibited the same trend of a positive correlation between BMI and severity 
of disease until stage I obesity—after which point the odds of severe CAD decreased with 
increasing BMI.  However, extreme obesity increased the odds of disease at a much higher rate 
in whites (Table 2, 5).  Black subjects consistently had both lower odds for severe stenosis and 
lower mean Gensini score for every BMI class when patients were compared to underweight 
subjects of their own race (Table 2).  When patients were compared to all other BMI classes 
within their own race, the protective effect of black race was diluted given the very low 
prevalence of severe CAD in the obese black subjects of this study (Table 5).  In our patient 
population, black obese patients were less likely to have a significant stenotic lesion than non-
obese blacks (Table 6, 7).  While not significant, there was a trend towards fewer stenotic 
lesions in obese whites compared to non-obese whites and a trend towards less disease in obese 
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patients of both races using the Gensini score.  Non-obese blacks were found to be significantly 
less likely than non-obese whites to have severe disease, while obese blacks are even less likely 
to have disease when compared to obese whites (Table 7). 
 
DISCUSSION 
Summary of findings 
 In our cohort of almost 6,000 white and black patients undergoing first-time elective 
angiography at a major academic medical center for suspected coronary artery disease, we found 
that black patients had consistently less disease than white patients despite having higher rates of 
obesity, hypertension, and diabetes.  This curious paradox of less disease despite greater risk 
factors was not only seen in black patients, but also obese patients.  Although the obese subgroup 
of our sample had a higher prevalence of hypertension, diabetes, hyperlipidemia, family history 
of CAD, and congestive heart failure, the very obese were consistently found to have much less 
disease than normal or even underweight subjects at otherwise similar risk.   
Odds of severe CAD rise for both races with increasing BMI until they peak at stage I 
obesity and then fall with worsening obesity.  While this inverted parabolic relationship is seen 
with both white and black patients, increasing BMI raises odds of CAD at a much greater rate in 
whites than in blacks.  Also, the drop in risk seen with severe obesity, when compared to the 
underweight subjects of the appropriate race, falls twice as much for black patients as it does for 
white patients.  Adjusting for CAD risk factors and demographics mitigated the difference in 
odds of disease between obese and non-obese patients and for those subjects with BMI 
classifications below morbid obesity.  Controlling for potential confounders did not remove the 
protective effect black race appears to have against CAD severity.   
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While both black race and obesity were found, independently, to be associated with less 
CAD when compared to white race and non-obesity, the protective effects of black race and 
obesity combined are summarized in the adjusted outcome findings across race by obesity status 
(Table 7).  In our sample, non-obese black patients are significantly less likely to have severe 
CAD than non-obese white patients, but that obese black patients are even less likely to have 
severe CAD compared to obese white patients.  Thus, black race and extreme obesity are 
paradoxically associated with less disease despite the higher prevalence of traditional risk factors 
and incidence of CAD-related cardiac events known to exist in both groups.  When black race 
and obesity overlap, the independently demonstrated safeguarding is amplified. 
How our study fits in the literature 
 Our sample resembles those of previous studies evaluating racial disparities in CAD risk 
factors.
41`  
Black patients tend to have higher rates of traditional risk factors for heart disease, 
including hypertension, obesity, and diabetes.  However, black patients in our sample had a 
lower percentage of those with family history of CAD and rates of smoking and hyperlipidemia 
were equivalent between white and black patients.  Also similar to past studies, we found in our 
study sample that traditional CAD risk factors were associated with the outcome measures for 
severe CAD.  Although some studies have examined the lower prevalence of angiographic CAD 
in black patients, no studies have combined the dual relationships of race with obesity and CAD.  
In similar studies, BMI has been found to have an inconsistent association with the presence of 
coronary atherosclerosis, although black-white disparities across obesity-imposed risk has not 
been examined as it has with our sample.  Similar studies typically use one or two angiographic 
outcomes to quantify atherosclerotic burden, though no studies have used the unique 
combination of our study’s dichotomous significant stenosis criteria and modified Gensini 
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score—used on both a continuous scale and as a dichotomous outcome for comparison of odds 
ratios. 
Limitations  
One limitation of the study is that race classification was based on information from the 
academic medical center’s records rather than self-identification.  While this is not ideal, it is a 
reality for most hospitals in the United States.
42
  The concern is for misclassification of race, 
which as been shown to happen on a small but significant scale in hospitals.  However, the effect 
of this misclassification is nondifferential and would minimize rather than amplify differences 
found between races.  Race itself is a difficult exposure variable to study, as it is a social 
classification without necessarily reflecting genetic distinction.
43
  The diverging effect of obesity 
in black and white subjects on prevalence of severe CAD is multifaceted and complex, involving 
disparities in access to care, and clinical management patterns along with socioeconomic, health 
behavior, lifestyle, and historical differences between these groups.   
Those who undergo coronary angiography are usually referred for signs or symptoms and 
thus the available data cannot accurately reflect the population at large—and thus the obese 
population at large.  An intrinsic weakness of the BMI metric is an inability to differentiate lean 
mass and body fat.  A short, very muscular patient can have the BMI of a tall, morbidly obese 
person without, of course, the same risk for atherosclerotic disease.  This potential inaccuracy is 
relatively rare and we attempted to mitigate this limitation of BMI as a measurement of obesity 
by dropping observations from the database with extreme values for height or weight.  Also, the 
relationship between BMI and adiposity varies across race; black patients have less body fat than 
their Caucasiancounterparts of the same BMI.
44
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Significance 
 We are unaware of any study to date with a primary focus on examining obesity as a 
contributing cause to the low rate of angiographic CAD in the black population.  However, other 
causal variables, such has hypertension,
45
 have been found to possibly influence the racial 
disparity.  Obesity, for whatever reason, has been demonstrated to be associated with lower rates 
of CAD.  Given that blacks have higher rates of obesity in comparison to whites, obesity 
provides a plausible, if not partial, explanation for the racial differences in rates of angiographic 
CAD.  Other explanations for black patients having less CAD on angiography include naturally 
more favorable lipid profiles, younger age, and greater compensatory vascular remodeling in 
comparison to white patients.
35,44 
How can obesity seemingly protect patients from angiographically detectable CAD when 
we know the link between elevated BMI and ultimate hallmarks of advanced CAD?  Obesity is 
an established risk factor for the development of heart disease and eventual cardiac morbidity 
and mortality.  However, we know that the association between obesity and coronary disease 
extends beyond cardiac events.  Excess adiposity not only predisposes patients to obesity-
associated risk factors for CAD such as hyperlipidemia, diabetes, and endothelial dysfunction, 
but can actually mimic the clinical signs and symptoms of ischemic heart disease.  Increased 
blood pressure, suppressed cardiac output, atypical chest pain, shortness of breath, increased 
systemic resistance with left ventricular hypertrophy, and decreased exercise tolerance can be 
direct or indirect effects of obesity.  Noninvasive screening and clinical testing to evaluate for 
heart disease including electrocardiograms, stress tests, and echocardiograms are fraught with 
false positives for obese patients due to the procedural difficulties posed by excess body fat.  
Often, primary care physicians and cardiologists refer obese patients for cardiac catheterization 
because of these screening and testing challenges simply to rule it out.  The rate of these 
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unwarranted referrals is likely higher in the very obese, where imaging, electrocardiography, and 
stress testing are particularly difficult—thus helping to explain the finding in this study of the 
morbidly obese to have significantly lower rates of CAD compared to other BMI classes.   
This study, and its models that show obesity to decrease a black patient’s already lower 
likelihood of angiographic CAD, provides credible evidence that adiposity may contribute to the 
black-white disparity seen in rates of atherosclerotic disease.  Cardiac catheterization for 
coronary angiography is an invasive procedure with considerable risks to the patient; a fuller 
understanding of how both black race and obesity may falsely elevate clinical suspicion for CAD 
could prevent unnecessary, potentially harmful cardiac catheterization in both groups.  The 
hypothesis-generating results of this study suggest that further studies on the relationship 
between race, obesity, and CAD can refine pretest probability estimations for these groups.  This 
remodeling of risk will improve clinical evaluation and management of patients with and without 
CAD. 
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Table 1. Patient Characteristics by Race 
Characteristic 
Total sample 
(n=5998) mean 
(SD) or % 
Black 
(n=1963) 
mean or % 
White (n=4022) 
mean or % p-value 
Age in years (n=5998) 56.90 (13.34) 53.82 58.41 <0.001 
% White (n=5995) 67.20    
% Male (n=5998) 52.52 45.13 56.12 <0.001 
 % BMI (kg/m2)  (n=5998) 
1. <18.5 (underweight) 
2. 18.5-24.9 (normal) 
3. 25-29.9 (OW) 
4. 30-34.9 (OB I) 
5. 35-39.9 (OB II) 
6. >40 (OB III) 
2.42 
23.52 
31.59 
20.77 
11.30 
10.39 
1.83 
19.21 
26.39 
22.47 
14.72 
15.38 
2.71 
25.68 
34.11 
19.89 
9.67 
7.93 <0.001 
% Obese (n=5998) 42.46 52.57 37.49 <0.001 
% former/current smokers (n=5654) 57.78 56.92 58.20 0.360 
% history of HTN (n=5826) 69.04 79.67 63.75 <0.001 
% history of HLD (n=5486) 49.09 48.46 49.42 0.168 
% history of diabetes (n=5998) 38.18 43.81 35.26 <0.001 
% with family history of CAD (n=5461) 36.07 31.33 38.39 <0.001 
% with CHF (n=5975) 37.89 43.40 35.21 <0.001 
Gensini score (n=5998) 8.20 (16.78) 5.58 9.46 <0.001 
% with severe stenosis (n=5998) 29.43 20.02 34.01 <0.001 
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Table 2. Bivariate Associations Between Patient Risk Factors and Outcomes by Race 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristic 
Significant 
Stenosis OR (95% 
CI) for Blacks 
Significant 
Stenosis OR (95% 
CI) for Whites 
Gensini 
Mean (SD) 
for Blacks        
Gensini Mean 
(SD) for 
Whites        
Gensini 
Mean P-
value 
for 
Blacks 
Gensini 
mean P-
value 
for 
Whites 
BMI (kg/m2)  
1. <18.5 (UW) 
2. 18.5-24.9 (NL) 
3. 25-29.9 (OW) 
4. 30-34.9 (OB I) 
5. 35-39.9 (OB II) 
6. >40 (OB III) 
 
 
1.00 
1.28 (0.52-3.19) 
1.52 (0.62-0.375) 
1.64 (0.67-4.05) 
1.10 (0.43-2.77) 
0.51 (0.20-1.33) 
 
 
1.00 
2.16 (1.32-3.53) 
2.46 (1.51-4.00) 
2.61 (1.59-4.29) 
1.82 (1.08-3.08) 
1.05 (0.61-1.82) 
 
 
3.94 (10.01) 
5.14 (11.67) 
7.06 (18.47) 
6.73 (15.81) 
5.39 (12.39) 
2.30 (8.76) 
 
 
6.05 (15.11) 
9.35 (16.92) 
10.47 (18.00) 
10.78 (20.62) 
8.13 (15.19) 
5.01 (12.15) 
 
<0.001 
 
<0.001 
Obesity Status:Obese 
        Non-obese 
 
0.80 (0.64-1.00) 
1.00 
 
0.89 (0.78-1.02) 
1.00 
 
5.06 (13.25) 
6.16 (15.79) 
 
8.88 (17.92) 
9.82 (17.47) 
0.093 
 
0.102 
 
Age 
1. <40 
2. 40-49 
3. 50-59 
4. 60-69 
5. 70-79 
6. >80 
 
 
 
1.0 
7.29 (2.90-18.34) 
12.27 (4.96-30.37) 
17.07 (6.85-42.53) 
25.09 (9.81-64.13) 
12.95 (4.08-41.14) 
 
 
 
1.0 
4.40 (2.68-7.23) 
6.44 (3.98-10.42) 
9.62 (5.94-15.57) 
12.76 (7.80-20.86) 
14.21 (8.39-24.07) 
 
 
 
1.01 (7.41) 
3.92 (12.97) 
5.66 (13.38) 
8.37 (18.33) 
9.11 (17.65) 
7.23 (12.59) 
 
 
 
1.88 (9.39) 
6.21 (14.12) 
7.72 (15.55) 
11.90 (20.21) 
13.94 (20.12) 
14.61 (19.64) 
 
 
 
 
 
<0.001 <0.001 
Sex:           Male 
 Female 
 
 
1.92 (1.52-2.41) 
1.00 
 
2.45 (2.13-2.82) 
1.00 
7.82 (17.52) 
3.74 (11.15) 
12.46 (20.13) 
5.63 (12.85) 
<0.001 
 
 
  
Smoking history: Yes 
 No 
 
 
1.69 (1.32-2.17) 
1.00 
 
 
1.64 (1.43-1.90) 
1.00 
 
 
6.82 (16.53) 
4.24 (11.94) 
 
 
11.05 (18.98) 
7.64 (15.27) <0.001 <0.001 
HTN: Yes 
No 
2.35 (1.66-3.38) 
1.00 
2.06 (1.77-2.38) 
1.00 
5.96 (14.01) 
4.31 (16.50) 
11.07 (18.58) 
6.81 (15.45) 0.046 <0.001 
HLD: Yes 
 No 
2.29 (1.80-2.92) 
1.00 
2.24 (1.95-2.58) 
1.00 
8.34 (17.35) 
3.57 (11.74) 
12.35 (18.78) 
7.25 (16.26) <0.001 <0.001 
Diabetes history: Yes 
 No 
1.46 (1.29-1.63) 
1.00 
1.51 (1.31-1.73) 
1.00 
6.65 (14.34) 
4.75 (14.61) 
10.89 (18.35) 
8.68 (17.20) 0.004 <0.001 
FHx of CAD: Yes 
No 
1.20 (0.93-1.55) 
1.00 
1.43 (1.24-1.65) 
1.00 
6.09 (15.25) 
5.42 (14.63) 
10.48 (18.21) 
8.92 (17.20) 0.370 0.009 
CHF: Yes 
No 
1.20 (0.96-1.51) 
1.00 
1.08 (0.94-1.24) 
1.00 
5.86 (15.39) 
5.42 (13.88) 
9.59 (17.58) 
9.31 (17.60) 0.513 0.619 
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Table 3: Patient Characteristics by BMI Class and Obesity Status 
Characteristi
c 
Underweig
ht (<18.5) 
mean (SD) 
or % 
Normal 
(18.5-
24.9) 
mean 
(SD) or % 
Overweig
ht (25-
29.9) 
mean 
(SD) or 
% 
Obese 
I (30-
34.9) 
mean 
(SD)  
or % 
Obese 
II (35-
39.9) 
mean 
(SD) or 
% 
Obese 
III 
(>40) 
mean 
(SD) or 
% 
p-
value 
Non-
Obes
e 
mean 
(SD) 
or % 
Obese 
mean 
(SD) 
or % 
p-
value 
Age in years 
52.8 (18.3) 58.7 (15.2) 58.6 
(13.2) 
56.3 
(11.8) 
54.7 
(11.3) 
52.3 
(11.0) 
<0.00
1 
58.4 
(14.3) 
 
54.9 
(11.6) 
<0.00
1 
% AA 
24.8 26.7 27.4 35.5 42.6 51.4 <0.00
1 27.0 
40.6 <0.00
1 
% Male 
51.7 53.8 61.7 53.9 43.5 29.1 <0.00
1 58.0 
45.0 <0.00
1 
% 
former/curren
t smokers 
57.7 60.4 60.6 57.5 51.9 50.4 <0.00
1 
60.4 
 
 
54.3 <0.00
1 
% history of 
HTN 
49.3 58.4 65.6 74.4 80.0 84.8 <0.00
1 
62.0 
 
78.4 <0.00
1 
% history of 
HLD 
27.4 38.9 49.7 54.6 55.4 56.5 <0.00
1 
44.5 
 
55.3 <0.00
1 
% history of 
diabetes 
23.5 27.1 33.7 41.5 50.9 59.9 <0.00
1 
30.6 
 
48.5 <0.00
1 
% with 
family history 
of CAD 
22.9 29.9 33.6 41.2 41.7 43.9 <0.00
1 
31.6 
 
 
42.0 <0.00
1 
% with CHF 40.1 38.6 36.2 38.2 37.6 40.6 0.405 37.3 38.7 0.285 
Gensini score 
5.5 (14.0) 8.2 (15.8) 9.5 (18.2) 9.4 
(19.2) 
7.0 
(14.1) 
3.4 
(10.7) 
<0.00
1 
8.8 
 
7.3 0.001 
% with severe 
stenosis 
18.6 30.3 33.3 33.6 25.1 14.8 <0.00
1 
31.4 
 
26.7 <0.00
1 
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Table 4: Adjusted and Unadjusted Comparisons by Race and Obesity to Dichotomous Outcomes 
Outcome Characteristic Unadjusted OR Adjusted OR 
Severe Stenosis Black race 0.49 (0.42-0.55) 0.57 (0.48-0.66) 
Obese 0.79 (0.71-0.89) 0.94 (0.81-1.09) 
Gensini Score > 
10 
Black race 0.48 (0.42-0.55) 0.56 (0.47-0.67) 
Obese 0.78 (0.69-0.89) 0.97 (0.83-1.13) 
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Table 5: Adjusted and Unadjusted Comparisons by Race and BMI Class to Dichotomous Outcomes 
 White Black 
Outcome BMI (kg/m
2
) Unadjusted 
OR (95% CI) 
Adjusted OR 
(95% CI) 
Unadjusted OR 
(95% CI) 
Adjusted OR 
(95% CI) 
Severe 
Stenosis 
<18.5 (UW) 0.45 (0.28-0.74) 0.57 (0.31-1.05) 0.80 (0.33-1.93) 0.83 (0.29-2.41) 
18.5-24.9 (nl) 1.00 (0.86-1.16) 1.00 (0.84-1.21) 1.03 (0.78-1.36) 0.98 (0.70-1.37) 
25-29.9 (OW) 1.22 (1.06-1.40) 1.02 (0.87-1.20) 1.31 (1.03-1.68) 1.17 (0.89-1.56) 
30-34.9 (OB I) 1.26 (1.08-1.49) 1.27 (1.05-1.54) 1.43 (1.11-1.84) 1.47 (1.10-1.97) 
35-39.9 (OB 
II) 
0.83 (0.66-1.04) 0.99 (0.76-1.28) 0.85 (0.62-1.19) 0.79 (0.55-1.15) 
>40 (OB III) 0.46 (0.35-0.61) 0.58 (0.41-0.80) 0.36 (0.24-0.54) 0.51 (0.33-0.79) 
Gensini 
Score > 10 
<18.5 (UW) 0.50 (0.30-0.84) 0.65 (0.34-1.24) 0.92 (0.36-2.39) 0.94 (0.30-2.95) 
18.5-24.9 (nl) 0.97 (0.83-1.14) 0.92 (0.76-1.13) 1.00 (0.73-1.37) 0.95 (0.65-1.40) 
25-29.9 (OW) 1.26 (1.09-1.46) 1.03 (0.87-1.23) 1.29 (0.99-1.70) 1.17 (0.85-1.60) 
30-34.9 (OB I) 1.20 (1.01-1.43) 1.27 (1.04-1.55) 1.40 (1.06-1.85) 1.31 (0.95-1.82) 
35-39.9 (OB 
II) 
0.92 (0.72-1.17) 1.14 (0.87-1.51) 1.03 (0.73-1.46) 1.04 (0.70-1.54) 
>40 (OB III) 0.39 (0.28-0.55) 0.50 (0.34-0.74) 0.28 (0.17-0.47) 0.42 (0.24-0.72) 
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Table 6: Unadjusted Outcome findings by race and obesity status 
 % of 
cohort 
% Obese % with Severe 
Stenosis 
p-value Mean Gensini Score 
(SD) 
p-value 
Whites, 
n=4022 
67.20 37.49 ob, n=1508 32.43  0.100 8.88 (17.92) 0.102 
62.51 n-ob, n=2514 34.26 9.82 (17.47) 
Blacks, 
n=1963 
32.80 52.57 ob, n=1032 18.31 0.047 5.06 (13.25) 0.093 
47.43 n-ob, n=931 21.91 6.16 (15.79) 
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Table 7: Adjusted Outcome Findings across Race by Obesity Status 
  
OR of severe 
stenosis p-value 
OR of Gensini > 
10 p-value 
Obese blacks 0.54 (0.43-0.67) <0.001 0.53 (0.41-0.68) <0.001 
Obese whites 
    Non-obese blacks 0.60 (0.49-0.75) <0.001 0.60 (0.47-0.76) <0.001 
Non-obese whites 
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Figure 1. Unadjusted OR for Significant Stenosis and Mean Gensini Score by BMI 
Classification for Black and White Patients 
                 *The OR for significant stenosis is based on the race-specifc, underweight BMI class as the referent     
(OR=1) category
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